MedTech Spectrum

Article Name Medtech innovation

BMI OrganBank Secures FDA Breakthrough Device Designation for Innovative Kidney Transplant Technology

BMI OrganBank is developing novel medical devices with potential to significantly reduce the waitlist for lifesaving organ transplants, beginning with kidneys

05th August, 2025

Demetra Launches Global Spine Division Following Strategic Acquisition of OrthoFundamentals

With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.

04th August, 2025

MiRus Secures NTAP Approval from CMS for Breakthrough EUROPA® Cervical Spine System

Awarded for its proprietary MoRe® alloy-based 2.9 mm rod, the EUROPA® PCF System offers a low-profile, high-strength solution for cervical and upper thoracic spine surgery—now eligible for Medicare reimbursement under the New Technology Add-on Payment programme.

04th August, 2025

Cortechs.ai Expands FDA-Cleared NeuroQuant® Brain Tumor with Automated Segmentation of Brain Metastases and Meningiomas

New AI models bring precision and speed to neuro-oncology, enabling fully automated volumetric analysis and seamless integration into radiology, surgery, and radiation oncology workflows—advancing diagnostic confidence and patient care.

31st July, 2025

Alafair Biosciences Earns Dual FDA 510(k) Clearances for VersaCoat™ Flowable Hydrogel

VersaCoat, a syringe-deliverable soft-tissue protector, brings Alafair’s proven hyaluronic acid and alginate formula to complex surgical sites—expanding its impact in orthopedic, trauma, and sports medicine procedures.

31st July, 2025

Johnson & Johnson MedTech Launches VIRTUGUIDE™ System to Transform Bunion Surgery with AI Precision

AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes

30th July, 2025

Siemens Healthineers Leads the Way in Laboratory Sustainability with ACT Ecolabel Certification for Over 150 Diagnostic Reagents

First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio

30th July, 2025

Athena Diagnostics Introduces Advanced Genetic Test to Detect Hidden Causes of Ataxia

Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders

30th July, 2025

Matrix Medical Network Partners with Molecular Testing Labs to Elevate Home-Based Diagnostics and Expand Access to Care

Strategic alliance enhances in-home screening with advanced molecular diagnostics, AI-driven insights, and flexible testing options to improve outcomes for patients and underserved communities.

29th July, 2025

Aptitude Medical Secures $9M BARDA Partnership to Advance Rapid Filovirus Diagnostic for Ebola and Marburg Detection

New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.

29th July, 2025

Linus Health Expands Access to AI-Powered Cognitive Assessments with Launch of ‘Anywhere’ Platform

Designed for seamless remote use, the ‘Anywhere powered by Linus Health™’ platform brings early detection of cognitive decline to payers, pharma, wellness providers, and consumers—anytime, anywhere.

29th July, 2025

Stereotaxis Secures FDA Clearance for MAGiC Sweep Catheter

New magnetic ablation catheter designed to enhance precision and reach in robotic electrophysiology procedures across the U.S.

28th July, 2025

Embolx Unveils Sniper G3: Next-Generation Pressure-Directed Microcatheter for Embolization

Designed for greater control, streamlined usability, and longer shelf life, Sniper G3 sets a new benchmark in targeted vascular intervention.

28th July, 2025

Quanterix Unveils Next-Generation p-Tau 205 and p-Tau 212 Assays to Propel Alzheimer’s Research

Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research.

28th July, 2025